Prevention

Dorothee Heemskerk; Maxine Caws; Ben Marais; Jeremy Farrar

doi:10.1007/978-3-319-19132-4_6

Prevention

Dorothee Heemskerk, Maxine Caws, Ben Marais, Jeremy Farrar

Clinical Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Prevention is the key to stop transmission of TB. It consists of early diagnosis and treatment of active TB to stop infectiousness, the prevention of active disease in exposed or known latently infected individuals and vaccination. Vaccination with the Bacillus Calmette-Guerin (BCG) vaccine is unfortunately largely ineffective in interrupting transmission. However a more powerful vaccine will have the potential to cause a major shift in the management of TB. In this chapter prophylactic treatment in latently infected and HIV infected patients is reviewed. Additionally the prevention of active disease in MDR-exposed persons and vaccine development will be discussed.

Original language	English
Title of host publication	SpringerBriefs in Public Health
Pages	51-56
Number of pages	6
DOIs	https://doi.org/10.1007/978-3-319-19132-4_6
Publication status	Published - 1 Jan 2015

Keywords

Latent tuberculosis
Prevention
Prophylactic treatment
Prophylactic treatment in multi-drug resistant tuberculosis
Vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-19132-4_6

Cite this

@inbook{57be57d2fd674747abe7f4fad9a48ac2,

title = "Prevention",

abstract = "Prevention is the key to stop transmission of TB. It consists of early diagnosis and treatment of active TB to stop infectiousness, the prevention of active disease in exposed or known latently infected individuals and vaccination. Vaccination with the Bacillus Calmette-Guerin (BCG) vaccine is unfortunately largely ineffective in interrupting transmission. However a more powerful vaccine will have the potential to cause a major shift in the management of TB. In this chapter prophylactic treatment in latently infected and HIV infected patients is reviewed. Additionally the prevention of active disease in MDR-exposed persons and vaccine development will be discussed.",

keywords = "Latent tuberculosis, Prevention, Prophylactic treatment, Prophylactic treatment in multi-drug resistant tuberculosis, Vaccine",

author = "Dorothee Heemskerk and Maxine Caws and Ben Marais and Jeremy Farrar",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-19132-4\_6",

language = "English",

pages = "51--56",

booktitle = "SpringerBriefs in Public Health",

}

TY - CHAP

T1 - Prevention

AU - Heemskerk, Dorothee

AU - Caws, Maxine

AU - Marais, Ben

AU - Farrar, Jeremy

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Prevention is the key to stop transmission of TB. It consists of early diagnosis and treatment of active TB to stop infectiousness, the prevention of active disease in exposed or known latently infected individuals and vaccination. Vaccination with the Bacillus Calmette-Guerin (BCG) vaccine is unfortunately largely ineffective in interrupting transmission. However a more powerful vaccine will have the potential to cause a major shift in the management of TB. In this chapter prophylactic treatment in latently infected and HIV infected patients is reviewed. Additionally the prevention of active disease in MDR-exposed persons and vaccine development will be discussed.

AB - Prevention is the key to stop transmission of TB. It consists of early diagnosis and treatment of active TB to stop infectiousness, the prevention of active disease in exposed or known latently infected individuals and vaccination. Vaccination with the Bacillus Calmette-Guerin (BCG) vaccine is unfortunately largely ineffective in interrupting transmission. However a more powerful vaccine will have the potential to cause a major shift in the management of TB. In this chapter prophylactic treatment in latently infected and HIV infected patients is reviewed. Additionally the prevention of active disease in MDR-exposed persons and vaccine development will be discussed.

KW - Latent tuberculosis

KW - Prevention

KW - Prophylactic treatment

KW - Prophylactic treatment in multi-drug resistant tuberculosis

KW - Vaccine

U2 - 10.1007/978-3-319-19132-4_6

DO - 10.1007/978-3-319-19132-4_6

M3 - Chapter

SP - 51

EP - 56

BT - SpringerBriefs in Public Health

ER -

Prevention

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this